[1]
Heimfarth, L. et al. 2021. Insights into the actions of angiotensin-1 receptor (AT1R) inverse agonists: Perspectives and implications in COVID-19 treatment. EXCLI Journal. 20, (Feb. 2021), 252–275. DOI:https://doi.org/10.17179/excli2021-3412.